These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7638988)

  • 1. Local hyperthermia and systemic chemotherapy for treatment of recurrent melanoma.
    Di Filippo F; Carlini S; Garinei R; Perri P; Anzà M; Ferranti F; Saracca E; Schiratti M; Cavaliere F; Cavaliere R
    World J Surg; 1995; 19(3):359-62. PubMed ID: 7638988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology.
    Overgaard J; Gonzalez Gonzalez D; Hulshof MC; Arcangeli G; Dahl O; Mella O; Bentzen SM
    Lancet; 1995 Mar; 345(8949):540-3. PubMed ID: 7776772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment.
    Hoekstra HJ; Schraffordt Koops H; de Vries LG; van Weerden TW; Oldhoff J
    Cancer; 1993 Aug; 72(4):1224-9. PubMed ID: 8393368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
    Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K
    Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology.
    Overgaard J; Gonzalez Gonzalez D; Hulshof MC; Arcangeli G; Dahl O; Mella O; Bentzen SM
    Int J Hyperthermia; 1996; 12(1):3-20. PubMed ID: 8676005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I-II trial of hyperthermic isolated limb perfusion with cisplatin in the treatment of high risk malignant melanoma of the extremities.
    Hajarizadeh H; Mueller CR; Woltering EA; Small K; Fletcher WS
    Melanoma Res; 1991; 1(1):55-61. PubMed ID: 1822770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated limb perfusion for recurrent melanoma of the extremity.
    Reintgen DS; Cruse CW; Wells KE; Saba HI; Slingluff CL
    Ann Plast Surg; 1992 Jan; 28(1):50-4. PubMed ID: 1642406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
    Atzpodien J; Lopez Hänninen E; Kirchner H; Franzke A; Körfer A; Volkenandt M; Duensing S; Schomburg A; Chaitchik S; Poliwoda H
    Eur J Cancer; 1995 Jun; 31A(6):876-81. PubMed ID: 7646914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival of patients with stage II melanoma of the extremity using hyperthermic isolation perfusion with 1-phenylalanine mustard.
    Hartley JW; Fletcher WS
    J Surg Oncol; 1987 Nov; 36(3):170-4. PubMed ID: 3682836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
    Kirchner HH; Atzpodien J; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy in malignant melanoma using dacarbazine, carmustine, cisplatin, and tamoxifen: a University of South Florida and H. Lee Moffitt Melanoma Center Study.
    Saba HI; Cruse CW; Wells KE; Klein CJ; Reintgen DS
    Ann Plast Surg; 1992 Jan; 28(1):60-4. PubMed ID: 1642408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of superficial and deep regional hyperthermia combined with systemic chemotherapy and radiotherapy in metastatic melanoma.
    Richtig E; Hoff M; Rehak P; Kapp K; Hofmann-Wellenhof R; Zalaudek I; Poschauko J; Uggowitzer M; Kohek P; Smolle J
    J Dtsch Dermatol Ges; 2003 Aug; 1(8):635-42. PubMed ID: 16296154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of the efficacy of diamminedichloroplatinum (cisplatin) for the control of locally recurrent and intransit malignant melanoma of the extremities using tourniquet outflow-occlusion techniques.
    Bland KI; Kimura AK; Brenner DE; Basinger MA; Hirsch M; Hawkins IF; Pierson KK; Copeland EM
    Ann Surg; 1989 Jan; 209(1):73-80. PubMed ID: 2910216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
    Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):607-18. PubMed ID: 10348291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
    Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
    Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: final results of cancer biotherapy research group 94-11.
    Dillman RO; Soori G; Wiemann MC; Schulof R; Dobbs TW; Ruben RH; DePriest CB; Church C
    Cancer Biother Radiopharm; 2000 Oct; 15(5):487-94. PubMed ID: 11155820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
    Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
    Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 plus chemotherapy for patients with metastatic melanoma.
    Paciucci PA; Ryder JS; Mandell JP; Morris JC; Holland JF
    Melanoma Res; 2000 Jun; 10(3):291-5. PubMed ID: 10890384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion.
    Di Filippo F; Calabrò A; Giannarelli D; Carlini S; Cavaliere F; Moscarelli F; Cavaliere R
    Cancer; 1989 Jun; 63(12):2551-61. PubMed ID: 2720604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined and complex treatment of patients with II-stage malignant skin melanoma using hyperthermia].
    Zhavrid EA; Fradkin SZ; Bezruchko VI; Firmanchuk AV; Proleskovskiĭ AK
    Vopr Onkol; 1986; 32(3):52-7. PubMed ID: 3962258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.